Literature DB >> 16304627

RC3/neurogranin is expressed in pyramidal neurons of motor and somatosensory cortex in normal and denervated monkeys.

Ana Guadaño-Ferraz1, Angel Viñuela, Guillermo Oeding, Juan Bernal, Estrella Rausell.   

Abstract

RC3/neurogranin is a neuron-specific calpacitin located in the cytoplasm and, especially, in dendrites and dendritic spines of cortical neurons, involved in many aspects of excitatory transmission and long-term potentiation. We investigated RC3 expression in pyramidal cortical neurons and interneurons of the motor and somatosensory cortex of normal Macaca fascicularis by means of double immunofluorescence and with techniques that combine immunohistochemistry and radioactive in situ hybridization. We show that RC3 is expressed in virtually all pyramidal neurons and spiny stellate neurons of neocortical areas 4, 3b, 1, 2, 5, 7, and SII, but not in the majority of cortical interneurons. RC3 protein and mRNA are tightly colocalized with the alpha subunit of CaM kinase II and the 200-kD, nonphosphorylated neurofilament, whereas they are absent from cells expressing the 27-kD, vitamin D-dependent calbindin and parvalbumin. In order to investigate possible activity-dependent regulation of the expression of RC3, we compared these results with those obtained from monkeys subjected to chronic peripheral cutaneous denervation of the first finger. We found that the pattern of distribution of RC3 in motor and somatosensory cortices after nerve cut did not differ from normal. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16304627     DOI: 10.1002/cne.20774

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  19 in total

1.  IQ-motif proteins influence intracellular free Ca2+ in hippocampal neurons through their interactions with calmodulin.

Authors:  Yoshihisa Kubota; John A Putkey; Harel Z Shouval; M Neal Waxham
Journal:  J Neurophysiol       Date:  2007-10-24       Impact factor: 2.714

2.  Multiplexed dendritic targeting of alpha calcium calmodulin-dependent protein kinase II, neurogranin, and activity-regulated cytoskeleton-associated protein RNAs by the A2 pathway.

Authors:  Yuanzheng Gao; Vedakumar Tatavarty; George Korza; Mikhail K Levin; John H Carson
Journal:  Mol Biol Cell       Date:  2008-02-27       Impact factor: 4.138

3.  Neurogranin binds α-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease.

Authors:  Andrew O Koob; Gideon M Shaked; Andreas Bender; Alejandro Bisquertt; Edward Rockenstein; Eliezer Masliah
Journal:  Brain Res       Date:  2014-10-19       Impact factor: 3.252

4.  Electroconvulsive therapy does not alter the synaptic protein neurogranin in the cerebrospinal fluid of patients with major depression.

Authors:  Laura Kranaster; Kaj Blennow; Henrik Zetterberg; Alexander Sartorius
Journal:  J Neural Transm (Vienna)       Date:  2017-10-23       Impact factor: 3.575

5.  Serum neurogranin measurement as a biomarker of acute traumatic brain injury.

Authors:  Jun Yang; Frederick K Korley; Min Dai; Allen D Everett
Journal:  Clin Biochem       Date:  2015-05-27       Impact factor: 3.281

6.  Neurogranin regulates sensorimotor gating through cortico-striatal circuitry.

Authors:  John M Sullivan; Caleb A Grant; Ashlie N Reker; Lailun Nahar; Nicholas E Goeders; Hyung W Nam
Journal:  Neuropharmacology       Date:  2019-03-19       Impact factor: 5.250

7.  Neurogranin-like immunoreactivity in the zebrafish brain during development.

Authors:  Anabel Alba-González; Julián Yáñez; Ramón Anadón; Mónica Folgueira
Journal:  Brain Struct Funct       Date:  2022-08-26       Impact factor: 3.748

8.  Lobe specific Ca2+-calmodulin nano-domain in neuronal spines: a single molecule level analysis.

Authors:  Yoshihisa Kubota; M Neal Waxham
Journal:  PLoS Comput Biol       Date:  2010-11-11       Impact factor: 4.475

Review 9.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

10.  Increased CSF neurogranin concentration is specific to Alzheimer disease.

Authors:  Henrietta Wellington; Ross W Paterson; Erik Portelius; Ulrika Törnqvist; Nadia Magdalinou; Nick C Fox; Kaj Blennow; Jonathan M Schott; Henrik Zetterberg
Journal:  Neurology       Date:  2016-01-29       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.